• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

作为变构蛋白的G蛋白偶联受体及变构调节剂的作用。

G protein coupled receptors as allosteric proteins and the role of allosteric modulators.

作者信息

Kenakin Terry

机构信息

GlaxoSmithKline Research and Development, Research Triangle Park, NC 27709, USA.

出版信息

J Recept Signal Transduct Res. 2010 Oct;30(5):313-21. doi: 10.3109/10799893.2010.503964.

DOI:10.3109/10799893.2010.503964
PMID:20858023
Abstract

Seven transmembrane receptors (7TMRs) are proteins that convey signals through changes in conformation. These conformations are stabilized by external molecules (i.e. agonists, antagonists, modulators) and act upon other bodies (termed 'guests') which can be other molecules in the extracellular space, or proteins along the plane of the membrane (receptor oligomerization) or signaling proteins in the cytosol (i.e. G protein, β-arrestin). These elements comprise allosteric systems and a great deal of 7TMR pharmacology can be considered in terms of allosteric behavior. Allosteric ligands acting on 7TMRs possess four unique behaviors that can be valuable therapeutically; (1) the ability to alter the interaction of very large proteins, (2) probe dependence, (3) saturable effect, and (4) induction of separate changes in affinity and efficacy of other ligands. Two of these behaviors (namely probe dependence for CCR5-based HIV-1 entry inhibitors and functional selectivity for biased agonism) will be highlighted with examples.

摘要

七跨膜受体(7TMRs)是一类通过构象变化传递信号的蛋白质。这些构象由外部分子(即激动剂、拮抗剂、调节剂)稳定,并作用于其他实体(称为“客体”),这些客体可以是细胞外空间中的其他分子、膜平面上的蛋白质(受体寡聚化)或胞质溶胶中的信号蛋白(即G蛋白、β-抑制蛋白)。这些元件构成变构系统,许多7TMR药理学可以从变构行为的角度来考虑。作用于7TMRs的变构配体具有四种独特的行为,在治疗上可能具有价值;(1)改变非常大的蛋白质相互作用的能力,(2)探针依赖性,(3)饱和效应,以及(4)诱导其他配体的亲和力和效力发生单独变化。将通过实例重点介绍其中两种行为(即基于CCR5的HIV-1进入抑制剂的探针依赖性和偏向激动作用的功能选择性)。

相似文献

1
G protein coupled receptors as allosteric proteins and the role of allosteric modulators.作为变构蛋白的G蛋白偶联受体及变构调节剂的作用。
J Recept Signal Transduct Res. 2010 Oct;30(5):313-21. doi: 10.3109/10799893.2010.503964.
2
Allosteric modulation of family C G-protein-coupled receptors: from molecular insights to therapeutic perspectives.家族 C G 蛋白偶联受体的别构调节:从分子见解到治疗视角。
Pharmacol Rev. 2011 Mar;63(1):59-126. doi: 10.1124/pr.109.002501. Epub 2011 Jan 12.
3
The role of conformational ensembles of seven transmembrane receptors in functional selectivity.七跨膜受体构象集合在功能选择性中的作用。
Curr Opin Pharmacol. 2010 Dec;10(6):775-81. doi: 10.1016/j.coph.2010.09.004.
4
When simple agonism is not enough: emerging modalities of GPCR ligands.当简单激动剂不够用时:G 蛋白偶联受体配体的新兴模式。
Mol Cell Endocrinol. 2011 Jan 15;331(2):241-7. doi: 10.1016/j.mce.2010.07.009. Epub 2010 Jul 21.
5
Allosteric properties of G protein-coupled receptor oligomers.G蛋白偶联受体寡聚体的变构特性。
Pharmacol Ther. 2007 Sep;115(3):410-8. doi: 10.1016/j.pharmthera.2007.06.004. Epub 2007 Jun 27.
6
Allosteric modulation of G protein-coupled receptors: perspectives and recent developments.G蛋白偶联受体的变构调节:观点与最新进展
Drug Discov Today. 2004 Sep 1;9(17):752-8. doi: 10.1016/S1359-6446(04)03220-9.
7
Collateral efficacy in drug discovery: taking advantage of the good (allosteric) nature of 7TM receptors.药物研发中的 collateral 效应:利用 7TM 受体的良好(变构)特性
Trends Pharmacol Sci. 2007 Aug;28(8):407-15. doi: 10.1016/j.tips.2007.06.009. Epub 2007 Jul 13.
8
Allosteric modulation of G protein-coupled receptors: a pharmacological perspective.变构调节 G 蛋白偶联受体:药理学视角。
Neuropharmacology. 2011 Jan;60(1):24-35. doi: 10.1016/j.neuropharm.2010.07.010. Epub 2010 Jul 15.
9
'7TM receptor allostery: putting numbers to shapeshifting proteins.7次跨膜受体变构:为变构蛋白定量
Trends Pharmacol Sci. 2009 Sep;30(9):460-9. doi: 10.1016/j.tips.2009.06.007. Epub 2009 Sep 2.
10
Modulating G-protein-coupled receptors: from traditional pharmacology to allosterics.调节G蛋白偶联受体:从传统药理学到变构调节
Trends Pharmacol Sci. 2007 Aug;28(8):431-7. doi: 10.1016/j.tips.2007.06.012. Epub 2007 Jul 17.

引用本文的文献

1
Structural basis of orientated asymmetry in a mGlu heterodimer.mGlu 异源二聚体定向不对称结构基础。
Nat Commun. 2024 Nov 28;15(1):10345. doi: 10.1038/s41467-024-54744-7.
2
Probing phosphorylation events in biological membranes: The transducer function.探测生物膜中的磷酸化事件:转换器功能。
Biochim Biophys Acta Biomembr. 2024 Oct;1866(7):184362. doi: 10.1016/j.bbamem.2024.184362. Epub 2024 Jun 15.
3
Quantification of ligand and mutation-induced bias in EGFR phosphorylation in direct response to ligand binding.定量分析配体和突变诱导的 EGFR 磷酸化在直接响应配体结合时的偏倚。
Nat Commun. 2023 Nov 21;14(1):7579. doi: 10.1038/s41467-023-42926-8.
4
Advances in the allostery of angiotensin II type 1 receptor.血管紧张素II 1型受体别构调节的研究进展
Cell Biosci. 2023 Jun 17;13(1):110. doi: 10.1186/s13578-023-01063-x.
5
Differential Activity of Orthosteric Agonists and Allosteric Modulators at Metabotropic Glutamate Receptor 7.变构调节剂和正构激动剂在代谢型谷氨酸受体 7 上的活性差异。
Mol Pharmacol. 2023 Jul;104(1):17-27. doi: 10.1124/molpharm.123.000678. Epub 2023 Apr 27.
6
Intermolecular Interactions in G Protein-Coupled Receptor Allosteric Sites at the Membrane Interface from Molecular Dynamics Simulations and Quantum Chemical Calculations.从分子动力学模拟和量子化学计算看跨膜 G 蛋白偶联受体变构位点的分子间相互作用。
J Chem Inf Model. 2022 Oct 10;62(19):4736-4747. doi: 10.1021/acs.jcim.2c00788. Epub 2022 Sep 30.
7
Probe Confined Dynamic Mapping for G Protein-Coupled Receptor Allosteric Site Prediction.用于G蛋白偶联受体变构位点预测的探针受限动态映射
ACS Cent Sci. 2021 Nov 24;7(11):1847-1862. doi: 10.1021/acscentsci.1c00802. Epub 2021 Sep 28.
8
International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function.国际基础和临床药理学联合会。CX. 5-羟色胺受体分类:药理学与功能。
Pharmacol Rev. 2021 Jan;73(1):310-520. doi: 10.1124/pr.118.015552.
9
A Novel Allosteric Activator of Free Fatty Acid 2 Receptor Displays Unique Gi-functional Bias.游离脂肪酸2受体的新型变构激活剂表现出独特的Gi功能偏向性。
J Biol Chem. 2016 Sep 2;291(36):18915-31. doi: 10.1074/jbc.M116.736157. Epub 2016 Jul 5.
10
Angiotensin II type I and prostaglandin F2α receptors cooperatively modulate signaling in vascular smooth muscle cells.血管紧张素II 1型受体与前列腺素F2α受体协同调节血管平滑肌细胞中的信号传导。
J Biol Chem. 2015 Jan 30;290(5):3137-48. doi: 10.1074/jbc.M114.631119. Epub 2014 Dec 15.